DIGI TAL HEALTH
scale this up and bring on all wards. Other connectivity solutions include
Mindray’s eGateway integration manager which provides a secure and bi-directional communication bridge – enabling the system to seamlessly integrate patient data from up to 1200 medical devices into third-party EPRs and other clinical information systems. BeneLink is a small plug-in device that forms the bridge between third-party bedside devices and patient monitors, allowing all monitoring data to be visible on one screen. In busy high-acuity environments where every second counts, having all bedside devices integrated into one screen helps provide clinicians with the rapid insight they need. “Ultimately, a connectivity solution needs to be easy for those implementing the systems – you don’t want one piece of software for high acuity patient monitoring and then another piece of software for infusion pumps. Ideally, it needs to be one platform, with just one interface into the EPR,” Mendonca explains.
The final piece in the puzzle is the Mindray Central Monitoring System (CMS) – a scalable solution that stores and distributes patient data from EPRs and networked medical devices to a range of display solutions, providing continuous clinical surveillance for enhanced patient safety.
Actionable data
While connectivity will be fundamental to the UK’s digital health ambitions, technology must ensure the vast amount of data collected is usable. Avoiding information overload – particularly in a pressured environment – is vital. Clinicians need to be able to read the data quickly and to act on it to improve patient outcomes. It is possible to capture much more than just vital signs, however. Increasingly, MedTech is assisting with clinical decision making – going beyond the capture of data to reducing the cognitive burden for clinicians and reducing variation in care
quality and patient outcomes. Clinical assistive apps that run on patient monitors can help with early warning scores, identification and treatment of sepsis, and orthostatic blood pressure reading, to name just a few of the many applications. With graphical clinical assistive applications, such as HemoSight, SepsisSight, and InfusionView, data from multiple clinical parameters are incorporated into intuitive views which allow clinicians, at the bedside, to capture trends in a patient’s condition at a glance.
These clinical assistive apps have the ability to save lives and to improve patient safety – sepsis, for example, accounts for 10% of ICU admissions and is associated with 10%–20% in-hospital mortality.4,5 Thirty million people suffer from sepsis every year around the globe and every 3-4 seconds one dies of the condition.6 Evidence shows that early treatment is associated with improved outcomes in these patients, and the ability to recognise the condition as soon as possible is therefore important.7
SepsisSight triggers an alert for early recognition of sepsis, to ensure prompt
response of clinicians to those patients with suspected sepsis.
Despite current initiatives that are aiming to improve sepsis awareness and early treatment, patient outcomes still depend upon the performance of accurate interventions which rely on proper individualisation of the treatment for each patient. Effective accomplishment of core interventions in sepsis demands a correct evaluation and requires a system that coordinates appropriate individualisation. As only approximately 50% of haemodynamically unstable patients in the ICU respond to a fluid challenge,8 indicators to guide fluid management in order to avoid positive fluid balance are needed. HemoSight offers a haemodynamic monitoring solution, which not only includes a variety of measurement methods, such as ICG, PiCCO, ScvO2
, CO, but also provides
comprehensive analysis tools. HemoSight focuses on the haemodynamic treatment process and provides appropriate tools for each stage.
Fluid responsiveness also needs to be cautiously evaluated before the fluids are given to the patients. HemoSight can help reflect fluid responsiveness by integrating multiple approaches including dynamic indices, such as pulse pressure variation (PPV)/ stroke volume variation (SVV). For rapid fluid loading tests or passive leg raise tests, changes in cardiac output need to be closely and continuously monitored and recorded. The interface of Mindray HemoSight can ensure the quality of these manoeuvres.
When septic patients are given vasopressors to treat severe hypotension, InfusionView also offers the real-time review of patient’s vital signs and helps clinicians easily observe patients’ responses to different dosage and rates to better individualise treatment. InfusionView also enables
JANUARY 2023
WWW.CLINICALSERVICESJOURNAL.COM l 45
▲
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
